ReviewChemistry, an Asian journal2026
Near-Field Communication-Enabled Wearable Chemical Sensors for Bioanalytical Monitoring.
Review in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This review evaluates the development and analytical potential of near-field communication (NFC)-enabled wearable chemical sensors for bioanalytical monitoring, including passive, battery-free, energy-buffered, and hybrid-energy architectures. Moving beyond conventional wireless data transmission, we emphasize how NFC-based power delivery and smartphone-interfaced readout interact with circuit design, flexible manufacturing, microfluidic biofluid handling, and target-specific interfacial chemistry. Representative applications in sweat, saliva, wound exudate, ocular fluids, and selected body-interfaced or portable point-of-care systems illustrate how sensing performance is governed by interfacial recognition and signal-transduction chemistry, together with sampling fidelity, reader coupling, calibration stability, and validation strategy. Although NFC-enabled sensors have achieved substantial miniaturization and functional integration, important limitations remain, including constrained power transfer, intermittent rather than truly continuous interrogation, calibration drift, biofouling, inter-device and smartphone-dependent variability, and limited real-world or clinical validation. Emerging directions such as hybrid energy harvesting, simplified analog readout, antifouling interfaces, and sensing-intervention integration offer promising opportunities, but their analytical robustness and translational relevance require rigorous assessment. Overall, this Review provides a chemical and analytical framework for evaluating NFC-enabled wearable sensing platforms and highlights the need for standardized validation before biofluid measurements are assigned clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.